BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34226019)

  • 1. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
    Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 3. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
    Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
    Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
    Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated quantitative DNA image cytometry system detects abnormal cells in cervical cytology with high sensitivity.
    Wong OG; Ho MW; Tsun OK; Ng AK; Tsui EY; Chow JN; Ip PP; Cheung AN
    Cytopathology; 2018 Jun; 29(3):267-274. PubMed ID: 29578257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
    Miralpeix E; Solé-Sedeño JM; Agramunt S; Lloveras B; Gimeno R; Alameda F; Carreras R; Mancebo G
    Int J Gynaecol Obstet; 2019 Oct; 147(1):43-48. PubMed ID: 31272132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
    Pajtler M; Milicić-Juhas V; Milojković M; Topolovec Z; Curzik D; Mihaljević I
    Coll Antropol; 2010 Mar; 34(1):81-6. PubMed ID: 20432737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
    Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
    BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
    Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
    Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
    Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
    J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.